Polyacrylamide Hydrogel Injection for Augmentation Mammaplasty
Authors:
- Dong-Lin LuoDLDong-Lin Luo
- Xia DaiXDXia Dai
- Pan YuPYPan Yu
- Ling TaoLTLing Tao
- Shi-Rong LiSLShi-Rong Li
- 1 August 2012
- journal article
- research article
- Published by Wolters Kluwer Health in Annals of Plastic Surgery
- Vol. 69 (2) , 123-128
Abstract
Polyacrylamide hydrogel (PAAG) has been widely used for injection augmentation mammaplasty in Russia, China, and Iran for more than 2 decades. In recent years, it has been advocated as a safe permanent filler for soft-tissue augmentation. However, the complications associated with PAAG injection in soft-tissue augmentation have not been extensively investigated. Augmentation mammaplasty through PAAG injection is associated with some complications. The incidence of infection during breastfeeding was reported to be higher than 50%. Herein, we report 58 cases of infection in breastfeeding women receiving PAAG injection, including 50 with unilateral injection (36 on the right, 14 on the left) and 8 bilateral injection. They experienced large breast autoinflation and some severe symptoms, such as local and systemic fever, breast swelling, nipple bulging, tenderness, and pain, which lead to surgical removal of galactocele or intraprosthetic collection of sterile pus resulting in deformity. Operation and comprehensive measures including removal of the injected material, clearing residual cavity, and pharmacotherapy were carried out to control infection and inflammation for 1 to 2 weeks. In the following 12 months, no relapse or recurrence of residual cavity was noted. Therefore, we do not recommend PAAG injection for augmentation mammaplasty, especially in women intending to breastfeed. Patients undergoing PAAG injection for augmentation mammaplasty should avoid breastfeeding. PAAG injection will cause serious consequences resulting in tissue atrophy and breast resection if inappropriately handled.Keywords
This publication has 12 references indexed in Scilit:
- Hyperprolactinemia and Galactocele Formation After Augmentation MammoplastyAnnals of Plastic Surgery, 2009
- Breast Cancer Following Augmentation Mammaplasty with Polyacrylamide Hydrogel (PAAG) InjectionAesthetic Plastic Surgery, 2009
- A Late Complication of Augmentation Mammoplasty by Polyacrylamide Hydrogel Injection: Ultrasound and Magnetic Resonance Imaging Findings of Huge Galactocele Formation in a Puerperal Woman with Pathological CorrelationThe Breast Journal, 2008
- Breast Autoinflation with Sterile Pus as a Marker of Implant Rupture: Single-Stage Treatment and Outcome for Five Consecutive CasesAesthetic Plastic Surgery, 2008
- Management of Postoperative Complications of Breast Augmentation by Injected Polyacrylamide HydrogelAesthetic Plastic Surgery, 2006
- An Uncommon Complication of Secondary Augmentation Mammoplasty:Bilaterally Massive Engorgement of Breasts After Pregnancy Attributable to Postinfection and Blockage of Mammary DuctsAesthetic Plastic Surgery, 2005
- ANALYSIS OF THE COMPLICATIONS INDUCED BY POLYACRYLAMIDE HYDROGEL INJECTIONPlastic and Reconstructive Surgery, 2004
- Long-Term Effects of Polyacrylamide Hydrogel on Human Breast TissuePlastic and Reconstructive Surgery, 2003
- Complications of Breast Augmentation with Injected Hydrophilic Polyacrylamide GelAesthetic Plastic Surgery, 2002
- Complications after injection mammaplastyAesthetic Plastic Surgery, 1992